Total Payments
$31,481
2024 Payments
$1,317
Companies
51
Transactions
302
Medicare Patients
914
Medicare Billing
$94,819
Payment Breakdown by Category
Other$10,650 (33.8%)
Food & Beverage$8,331 (26.5%)
Consulting$7,088 (22.5%)
Travel$4,675 (14.8%)
Education$738.00 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,650 | 5 | 33.8% |
| Food and Beverage | $8,331 | 253 | 26.5% |
| Consulting Fee | $7,088 | 5 | 22.5% |
| Travel and Lodging | $4,675 | 10 | 14.8% |
| Education | $738.00 | 29 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $18,003 | 31 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $5,240 | 6 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $1,107 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $708.14 | 16 | $0 (2024) |
| PFIZER INC. | $556.09 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $503.34 | 13 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $476.84 | 15 | $0 (2023) |
| Incyte Corporation | $421.06 | 5 | $0 (2019) |
| Genentech USA, Inc. | $378.29 | 17 | $0 (2024) |
| Puma Biotechnology, Inc. | $310.77 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,317 | 27 | AstraZeneca Pharmaceuticals LP ($241.53) |
| 2023 | $557.41 | 22 | AbbVie Inc. ($85.50) |
| 2022 | $1,132 | 41 | E.R. Squibb & Sons, L.L.C. ($242.92) |
| 2021 | $1,043 | 30 | PFIZER INC. ($208.53) |
| 2020 | $985.34 | 15 | Celgene Corporation ($690.41) |
| 2019 | $1,693 | 58 | Puma Biotechnology, Inc. ($278.83) |
| 2018 | $1,460 | 48 | Celgene Corporation ($356.39) |
| 2017 | $23,293 | 61 | Celgene Corporation ($16,757) |
All Payment Transactions
302 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Education | In-kind items and services | $34.88 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: CELLT | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.58 | General |
| Category: Oncology | ||||||
| 11/18/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $162.54 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: Oncology | ||||||
| 09/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: Oncology | ||||||
| 08/22/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $105.37 | General |
| Category: DESMOID TUMORS | ||||||
| 08/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $87.86 | General |
| 08/01/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Oncology | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $121.60 | General |
| 04/20/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $103.79 | General |
| Category: Oncology | ||||||
| 03/20/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Genentech USA, Inc. | Columvi (Biological), Gazyva, Lunsumio | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: BioOncology | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $93.98 | General |
| Category: Oncology | ||||||
| 02/21/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $118.50 | General |
| Category: Oncology | ||||||
| 02/20/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: ONCOLOGY | ||||||
| 02/14/2024 | Genentech USA, Inc. | Alecensa (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 353 | 524 | $91,697 | $32,968 |
| 2022 | 4 | 117 | 219 | $38,529 | $15,719 |
| 2021 | 3 | 128 | 225 | $36,837 | $15,279 |
| 2020 | 6 | 316 | 485 | $87,259 | $30,853 |
Total Patients
914
Total Services
1,453
Medicare Billing
$94,819
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 88 | 190 | $38,755 | $13,796 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 173 | 202 | $26,588 | $9,982 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 89 | $15,821 | $5,801 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 31 | 31 | $7,545 | $3,128 | 41.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 12 | $2,988 | $260.98 | 8.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 165 | $27,651 | $12,296 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $4,896 | $1,828 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 22 | $2,496 | $956.70 | 38.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 14 | $3,486 | $637.68 | 18.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 162 | $26,504 | $12,211 | 46.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 39 | $4,497 | $1,883 | 41.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 18 | 24 | $5,836 | $1,186 | 20.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 166 | 327 | $58,851 | $21,386 | 36.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 35 | 35 | $10,170 | $3,486 | 34.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 43 | 47 | $6,057 | $2,163 | 35.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 49 | $5,875 | $1,785 | 30.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $4,186 | $1,677 | 40.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 15 | 15 | $2,120 | $356.26 | 16.8% |
About Dr. Peter Rubin, M.D
Dr. Peter Rubin, M.D is a Internal Medicine healthcare provider based in Biddeford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912950411.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Rubin, M.D has received a total of $31,481 in payments from pharmaceutical and medical device companies, with $1,317 received in 2024. These payments were reported across 302 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,650).
As a Medicare-enrolled provider, Rubin has provided services to 914 Medicare beneficiaries, totaling 1,453 services with total Medicare billing of $94,819. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Medical Oncology
- Location Biddeford, ME
- Active Since 05/18/2006
- Last Updated 01/04/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912950411
Products in Payments
- Revlimid (Drug) $13,453
- SOLIRIS (Drug) $5,240
- OPDIVO (Biological) $721.22
- XTANDI (Drug) $367.63
- Imbruvica (Drug) $365.76
- NINLARO (Drug) $322.54
- Nerlynx (Drug) $294.49
- IMBRUVICA (Drug) $259.29
- Abraxane (Drug) $256.79
- LYNPARZA (Drug) $216.87
- TAZVERIK (Drug) $214.55
- KISQALI (Drug) $177.03
- BLENREP (Biological) $165.45
- Optune (Device) $162.54
- Xtandi (Drug) $136.13
- Perjeta (Biological) $131.33
- Padcev (Drug) $130.92
- FOUNDATIONONE (Device) $123.11
- Vectibix (Biological) $121.60
- CALQUENCE (Drug) $120.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Biddeford
Yasmin Mahal, Do, DO
Internal Medicine — Payments: $2,642
Internal Medicine $2,642
Steven Cutone, D.o, D.O
Internal Medicine — Payments: $2,606
Internal Medicine $2,606
Jennifer Cutone, M.d, M.D
Internal Medicine — Payments: $2,262
Internal Medicine $2,262
Dr. Mahesh Bandara, M.d, M.D
Internal Medicine — Payments: $1,733
Internal Medicine $1,733
Dr. Woodrow Lee, Do, DO
Internal Medicine — Payments: $1,712
Internal Medicine $1,712
Dr. Maureen Lee, D.o, D.O
Internal Medicine — Payments: $1,636
Internal Medicine $1,636